Cargando…

Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy

Aurora kinase A (AURKA) belongs to the family of serine/threonine kinases, whose activation is necessary for cell division processes via regulation of mitosis. AURKA shows significantly higher expression in cancer tissues than in normal control tissues for multiple tumor types according to the TCGA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Ruijuan, Huang, Chuntian, Liu, Kangdong, Li, Xiang, Dong, Zigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809767/ https://www.ncbi.nlm.nih.gov/pubmed/33451333 http://dx.doi.org/10.1186/s12943-020-01305-3

Ejemplares similares

PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy
por: Luo, Qian, et al.
Publicado: (2022)

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo
por: Jia, Xuechao, et al.
Publicado: (2021)

Bioinformatics and experimental validation of an AURKA/TPX2 axis as a potential target in esophageal squamous cell carcinoma
por: Du, Ruijuan, et al.
Publicado: (2023)

Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer
por: Ozawa, Hiroki, et al.
Publicado: (2021)

The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?
por: Liu, Hui, et al.
Publicado: (2021)

Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells
por: Yang, Yan, et al.
Publicado: (2020)

PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential
por: Huang, Hai, et al.
Publicado: (2021)

Integrated pan‐cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance
por: Miralaei, Noushin, et al.
Publicado: (2021)

Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer
por: Ton, Anh-Tien, et al.
Publicado: (2020)

LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA
por: Zhen, Hongtao, et al.
Publicado: (2021)

AURKA inhibition mimics BRCAness
por: Hirst, Jeff, et al.
Publicado: (2017)

Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities
por: Talib, Wamidh H., et al.
Publicado: (2021)

The expression of AURKA is androgen regulated in castration-resistant prostate cancer
por: Kivinummi, Kati, et al.
Publicado: (2017)

STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer
por: Li, Jingxian, et al.
Publicado: (2023)

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth
por: Jia, Xuechao, et al.
Publicado: (2023)

Targeting megakaryocytic induced fibrosis by AURKA inhibition in the myeloproliferative neoplasms
por: Wen, Qiang Jeremy, et al.
Publicado: (2015)

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted Therapy
por: Harbin, Laura M., et al.
Publicado: (2022)

Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway
por: Zhao, Jing, et al.
Publicado: (2023)

Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer
por: Guo, Mengjie, et al.
Publicado: (2018)

Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges
por: Chen, Yuchen, et al.
Publicado: (2018)

Ovarian Cancer: Opportunity for Targeted Therapy
por: Tagawa, Tomoko, et al.
Publicado: (2012)

UPS: Opportunities and challenges for gastric cancer treatment
por: Yang, Hang, et al.
Publicado: (2023)

Stem cells in cancer therapy: opportunities and challenges
por: Zhang, Cheng-Liang, et al.
Publicado: (2017)

Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer
por: Boos, Sophie L., et al.
Publicado: (2021)

CDK12 and PAK2 as novel therapeutic targets for human gastric cancer
por: Liu, Hui, et al.
Publicado: (2020)

Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers
por: Yang, Chuang, et al.
Publicado: (2023)

Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells
por: Liu, Ying, et al.
Publicado: (2016)

AURKA Gene Variants rs1047972, and rs8173 Are Associated With Breast Cancer
por: Maciel-Cruz, Eric Jonathan, et al.
Publicado: (2023)

Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC
por: Li, Mingzhu, et al.
Publicado: (2023)

Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo
por: Zhang, Man, et al.
Publicado: (2021)

PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer
por: Long, Qian, et al.
Publicado: (2020)

Exploring Natural Products as Radioprotective Agents for Cancer Therapy: Mechanisms, Challenges, and Opportunities
por: Zhang, Yi, et al.
Publicado: (2023)

Molecular Interplay between AURKA and SPOP Dictates CRPC Pathogenesis via Androgen Receptor
por: Nikhil, Kumar, et al.
Publicado: (2020)

Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
por: Wu, Changjie, et al.
Publicado: (2018)

Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan
por: Chou, Chia-Hsuan, et al.
Publicado: (2017)

Evaluation of the Association between Androgen Receptor and AURKA and Its Prognostic Value in Gastric Cancer
por: Soleymani Fard, Shahrzad, et al.
Publicado: (2019)

Epigenetic regulation of AURKA by miR-4715-3p in upper gastrointestinal cancers
por: Gomaa, Ahmed, et al.
Publicado: (2019)

Impacts of AURKA Genetic Polymorphism on Urothelial Cell Carcinoma Development
por: Huang, Chia-Hung, et al.
Publicado: (2019)

CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
por: Chen, Xi, et al.
Publicado: (2022)

The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
por: Neophytou, Christiana M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_528g1f32dp3fcgemu4u4oi6tos